AMBRX BIOPHARMA INC
SPONSORED ADS · CUSIP 02290A102
1
institutional holders
-44 vs Q3 2023
58.2k
shares reported held*
$828.6kreported value*
1 new
0 added
0 reduced
44 sold out
net sold ≈ $702.4m (-49.3m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $14.24.
Trends to Q4 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 17 |
| Q4 2022 | 19 |
| Q1 2023 | 31 |
| Q2 2023 | 43 |
| Q3 2023 | 45 |
| Q4 2023 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 7 | 12 |
| Q1 2023 | 26 | 8 |
| Q2 2023 | 31 | 15 |
| Q3 2023 | 33 | 19 |
| Q4 2023 | 1 | 44 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q1 2023 | $13.1m | $2.3m | 0.18 |
| Q2 2023 | $4.9m | $3.9m | 0.80 |
| Q3 2023 | $17.6m | $4.7m | 0.27 |
| Q4 2023 | $0 | $0 | — |
Biggest buyers
| Connective Capital Management, LLC | New | +58.2k |
Biggest sellers
| Darwin Global Management, Ltd. | Sold out | -16.7m |
| Cormorant Asset Management, LP | Sold out | -9.9m |
| D. E. Shaw & Co., Inc. | Sold out | -4.0m |
| Commodore Capital LP | Sold out | -3.5m |
| Paradigm Biocapital Advisors LP | Sold out | -3.5m |
| FEDERATED HERMES, INC. | Sold out | -2.4m |
| Venrock Adviser, LLC | Sold out | -2.1m |
| FMR LLC | Sold out | -1.8m |
| PRICE T ROWE ASSOCIATES INC /MD/ | Sold out | -821.6k |
| CITADEL ADVISORS LLC | Sold out | -768.8k |
Holders, Q4 2023
| Manager | Shares | Change |
|---|---|---|
| Connective Capital Management, LLC 0.70% of their portfolio | 58.2k $828.6k | New |